INOVIO PHARMACEUTICALS, INC. Debt Securities, Available-for-sale, Realized Gain (Loss)
INOVIO PHARMACEUTICALS, INC. (INO) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $145.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2019-11-12
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2019-09-30 was $145.00K.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2019-06-30 was $129.00K.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2018-09-30 was -$184.00K.
- INOVIO PHARMACEUTICALS, INC. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2018-06-30 was -$121.00K.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month |
|---|---|---|---|
| 2019-09-30 | $145.00K 10-Q · filed 2019-11-12 | $274.00K derived: sum of 2 quarters · filed 2019-11-12 | $238.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $129.00K 10-Q · filed 2019-08-08 | $93.00K 10-Q · filed 2019-08-08 | |
| 2018-09-30 | -$184.00K 10-Q · filed 2019-11-12 | -$305.00K derived: sum of 2 quarters · filed 2019-11-12 | -$558.00K 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$121.00K 10-Q · filed 2019-08-08 | -$374.00K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |